Manuela Zanni

2.0k total citations
35 papers, 713 citations indexed

About

Manuela Zanni is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Manuela Zanni has authored 35 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 12 papers in Genetics. Recurrent topics in Manuela Zanni's work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CAR-T cell therapy research (9 papers). Manuela Zanni is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CAR-T cell therapy research (9 papers). Manuela Zanni collaborates with scholars based in Italy, France and Switzerland. Manuela Zanni's co-authors include Corrado Tarella, Alessandro M. Gianni, Tiziano Barbui, Paolo Corradini, Sergio Cortelazzo, Alessandro Rambaldi, Francesco Zallio, Anna Dodero, Pinuccia Valagussa and Gianluca Gaïdano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Manuela Zanni

31 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuela Zanni Italy	11	639	376	189	178	146	35	713
Alvaro J. Alencar United States	10	369 0.6×	241 0.6×	162 0.9×	118 0.7×	162 1.1×	58	691
F Loong China	11	386 0.6×	282 0.8×	119 0.6×	69 0.4×	154 1.1×	19	612
Jeffrey Tang Canada	5	556 0.9×	353 0.9×	124 0.7×	233 1.3×	106 0.7×	8	714
Vít Procházka Czechia	16	423 0.7×	260 0.7×	48 0.3×	207 1.2×	142 1.0×	79	584
Helle Toldbod Denmark	9	513 0.8×	405 1.1×	55 0.3×	145 0.8×	244 1.7×	13	804
Abdulwahab J. Al-Tourah Canada	9	525 0.8×	364 1.0×	42 0.2×	189 1.1×	150 1.0×	18	616
Heidi Nyman Finland	11	501 0.8×	348 0.9×	38 0.2×	208 1.2×	189 1.3×	22	647
Mei Dong China	14	442 0.7×	379 1.0×	58 0.3×	68 0.4×	177 1.2×	49	775
Wing-Yan Au China	5	658 1.0×	531 1.4×	60 0.3×	74 0.4×	315 2.2×	5	755
Lucile Baseggio France	15	591 0.9×	249 0.7×	37 0.2×	473 2.7×	164 1.1×	50	766

Countries citing papers authored by Manuela Zanni

Since Specialization

Citations

This map shows the geographic impact of Manuela Zanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Zanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Zanni more than expected).

Fields of papers citing papers by Manuela Zanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Zanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Zanni. The network helps show where Manuela Zanni may publish in the future.

Co-authorship network of co-authors of Manuela Zanni

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Zanni. A scholar is included among the top collaborators of Manuela Zanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Zanni. Manuela Zanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pietrasanta, Daniela, et al.. (2023). The role of Bruton’s kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib. Journal of Basic and Clinical Physiology and Pharmacology. 34(3). 401–404. 3 indexed citations

Pietrasanta, Daniela, Alessia Castellino, Federico Monaco, et al.. (2023). Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice. Cancers. 15(22). 5397–5397. 6 indexed citations

Zanni, Manuela, et al.. (2021). Mesh repair for lateral inguinal hernias: a non-evidence-based practice. Hernia. 25(5). 1183–1187. 1 indexed citations

Pulsoni, Alessandro, Maria Elena Tosti, Simone Ferrero, et al.. (2020). “Miro” Study, a FIL multicenter phase II trial combining local radiotherapy and MRD-driven immunotherapy in early-stage follicular lymphoma.. Journal of Clinical Oncology. 38(15_suppl). e20073–e20073. 1 indexed citations

Santoro, Armando, Rita Mazza, Alessandro Pulsoni, et al.. (2020). Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma. Blood Advances. 4(1). 136–140. 22 indexed citations

Merli, Francesco, Federica Cavallo, Flavia Salvi, et al.. (2019). Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. Journal of Geriatric Oncology. 11(1). 37–40. 15 indexed citations

Chiappella, Annalisa, Cristiana Carniti, Andrea Evangelista, et al.. (2018). Romidepsin-CHOEP Plus Intensification with up-Front Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: Final Results of Phase Ib PTCL13 Study of the Fondazione Italiana Linfomi. Blood. 132(Supplement 1). 2902–2902. 3 indexed citations

Rossi, Davide, Fary Diop, Elisa Spaccarotella, et al.. (2017). Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 129(14). 1947–1957. 181 indexed citations

Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations

10.

Chiappella, Annalisa, Alessandra Tucci, Alessia Castellino, et al.. (2013). Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. Haematologica. 98(11). 1732–1738. 42 indexed citations

11.

Zanni, Manuela, Vincent Servois, Patricia Validire, et al.. (2012). Value of¹⁸FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience. Hematology. 17(2). 76–84. 21 indexed citations

12.

Vitolo, Umberto, Annalisa Chiappella, Angelo Michele Carella, et al.. (2010). Prospective, Multicenter Phase I–II Pilot Trial to Evaluate Efficacy and Safety of Lenalidomide Plus Rituximab-CHOP21 (LR-CHOP21) for Elderly Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis of the Intergruppo Italiano Linfomi (IIL) REAL07 Study. Blood. 116(21). 2871–2871. 4 indexed citations

13.

Validire, Patricia, Bernard Asselain, Youlia Kirova, et al.. (2008). Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors. American Journal of Hematology. 84(3). 133–139. 65 indexed citations

14.

Validire, Patricia, Christophe Fermé, Pauline Brice, et al.. (2008). A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. Anti-Cancer Drugs. 19(3). 309–315. 7 indexed citations

15.

Ladetto, Marco, Sonia Vallet, Fabio Benedetti, et al.. (2006). Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial. Leukemia. 20(10). 1840–1847. 12 indexed citations

16.

Corradini, Paolo, Corrado Tarella, Francesco Zallio, et al.. (2006). Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia. 20(9). 1533–1538. 189 indexed citations

17.

Ladetto, Marco, Michele Magni, G Pagliano, et al.. (2006). Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma. Biology of Blood and Marrow Transplantation. 12(12). 1270–1276. 43 indexed citations

18.

Ricardi, Umberto, Andrea Riccardo Filippi, Alessandra Cuttica, et al.. (2005). Rituximab followed by localized radiation therapy in limited stage indolent non-Hodgkin’s lymphoma: Preliminary results of a pilot study. Journal of Clinical Oncology. 23(16_suppl). 6696–6696. 1 indexed citations

19.

Tarella, Corrado, Manuela Zanni, Massimo Di Nicola, et al.. (2005). High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).. Blood. 106(11). 2068–2068. 1 indexed citations

20.

Tarella, Corrado, et al.. (2004). Intensive Chemotherapy in Patients with Lymphoma. Contributions to nephrology. 93–104. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact